NOS3 and metabolic syndrome: In the Iranian population, nitric oxide synthase 3 (NOS3)‐c.894G>T was found to be associated with an increased MetS risk in Iranian–Azerbaijanis, with the BMI influencing the effects of NOS3‐c.894G>T genotypes on MetS risk.13